PRESS RELEASE – Coronavirus: the commitment and dedication of Farma Industria Ticino associated companies 30 March 2020
New Insights on Mechlorethamine/Chlormethine gel presented at 4th World Congress of Cutaneous Lymphomas 14 February 2020
Lyfebulb and Helsinn Announce the Winners of the Third Annual Lyfebulb-Helsinn Cancer Innovation Summit & Award 31 January 2020
Helsinn Group Grants Exclusive Licensing Rights to Berlin-Chemie AG, a company of the Menarini Group, for ONICIT®/ALOXI® and AKYNZEO® in Russia and CIS region 27 January 2020
Helsinn to present a scientific poster on acute care use following CINV prophylaxis with agents in breast cancer patients at the San Antonio Breast Cancer Symposium (SABCS) 2019 16 December 2019
Helsinn Advanced Synthesis, Biasca: Reduces CO2 emissions by 80% and unveils the new anticancer plant 22 November 2019
Linkedin